NeRRe Therapeutics, Ltd.

Venture capital investment in biopharmaceutical companies during the second quarter brought another set of staggering numbers, with 257 firms raising $8.9bn – the second highest quarterly dollar total

It was a successful quarter for the UK biotech sector, driven by a string of sizeable venture capital deals, initial public offerings and follow-on financings and the money has continued to roll in th

Formed just three years ago, the UK's KaNDy Therapeutics Ltd. and its promising non-hormonal menopause drug for hot flashes and night sweats have been acquired by Bayer AG in a deal that could be

KaNDy Therapeutics is all set to move its non-hormonal menopause drug NT-814 into late-stage trials on the back of positive Phase IIb data which shows that the UK firm's therapy significantly improve